FluoroTau

N/A

Report date: 2025/11/24 11:49:08

Base Information

Drug NameFluoroTau
Drug Alias NameFluorine-18-THK 5351[18F]THK-5351GE-216F-18-THK-5351
ClassificationSmall molecules > Heterocyclic drugsDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agent +[5] 
Mechanisms of ActionPositron-emission tomography enhancersMicrotubule-associated protein tau inhibitors
TargetsMicrotubule-associated protein tau
Therapy Area/IndicationsCognitive DysfunctionDiabetes MellitusNeurodegenerative Diseases +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTohoku University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKorea Health Industry Development InstituteColumbia UniversityNational Cancer Institute +[4] 
Active IndicationsN/A
Inactive IndicationsCognitive DysfunctionDiabetes MellitusNeurodegenerative Diseases +[8] 

Other Information

ATC CodeN/A
Related LinksN/A